ANDA 215541, held by Leading. Metyrosine.
As of Nov 15, 2026, ANDA 215541 (Metyrosine), held by Leading, was first approved by FDA on Sep 17, 2024, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 17, 2024 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Metyrosine250MG ยท capsule;oral | Metyrosine | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
